[ORGANIZATION]
GlaxoSmithKline
Featured in 15 tracked stories · first seen
Situations
Italy influenza, COVID-19 and RSV vaccination rollout
33 clusters · 258 sources · last updated
Latest: Italy influenza vaccination campaign and respiratory virus trends
The 2026-2027 seasonal vaccination campaign in Italy, targeting influenza, COVID-19, and Respiratory Syncytial Virus (RSV), is underway. While some regions report growth, others face logistical and supply challenges. In
Egyptian market volatility follows record capitalisation
18 clusters · 21 sources · last updated
Latest: Egyptian stock market indices rise during early Sunday trading
Following a period of institutional selling in late September, the Egyptian Exchange experienced continued volatility. On September 29, the benchmark EGX30 fell 0.33% to close at 52,297 points. Although an intraday recov
Italian health and insurance economic sectors
2 clusters · 55 sources · last updated
Latest: Italy health and food sectors face economic and demographic shifts
The Italian insurance market experienced growth in 2025, with total premiums reaching 182 billion euros, a 7.8% increase from the previous year. Data from ANIA indicates the non-life sector rose by 6.5%, influenced by ri
Global vaccine market growth and technology trends
2 clusters · 5 sources · last updated
Latest: Japan industrial robotics market projected to reach $3.18 billion by 2035
The global vaccine sector is experiencing significant growth across different segments. The vaccine delivery device market is projected to expand from $8.1 billion in 2025 to $17.1 billion by 2035, driven by immunization
Also covered in
-
Gavi: New TB vaccines could save 7.3 million lives by 2050
[HEALTH] · 10 sources ·
-
Grifols appoints Joanna Le Couilliard as independent board member
[BUSINESS] · 2 sources ·
-
Colombia's lupus patients are overwhelmingly women, GSK data shows
[HEALTH] · 3 sources ·
-
Guña Rieder Leads GSK Korea's 40th Anniversary Push for Patient‑Centered Innovation
[BUSINESS] · 3 sources ·